Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 36 (3) , 327-332
- https://doi.org/10.1016/s0169-5002(02)00003-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999
- Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.Journal of Clinical Oncology, 1998
- Treatment of small cell lung carcinoma in the elderlyCancer, 1996
- Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow upAnnals of Oncology, 1996
- Full Chemotheraphy in Elderly Patients with Small Cell Bronchial CarcinomaActa Oncologica, 1996
- Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung CancerOncology, 1996
- Treatment of Small Cell Lung Cancer in the ElderlyJournal of the American Geriatrics Society, 1994
- Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patientsEuropean Journal Of Cancer, 1993
- Retrospective review of chemotherapy for small cell lung cancer in the elderly: Does the end justify the means?European Journal of Cancer and Clinical Oncology, 1991
- Cancer in the elderly: why so badly treated?The Lancet, 1990